4//SEC Filing
Carbylan Therapeutics, Inc. 4
Accession 0000899243-15-002410
$KALVCIK 0001348911operating
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 4:27 PM ET
Size
5.5 KB
Accession
0000899243-15-002410
Insider Transaction Report
Form 4
Renzi David
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2015-08-03+276,506→ 276,506 totalExercise: $6.91Exp: 2025-08-03→ Common Stock (276,506 underlying)
Footnotes (1)
- [F1]The option shall vest with respect to 1/48 of the underlying shares upon each monthly anniversary of the vesting commencement date of August 1, 2015.
Documents
Issuer
Carbylan Therapeutics, Inc.
CIK 0001348911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001348911
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 4:27 PM ET
- Size
- 5.5 KB